171 Recruiting Endometrial Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Endometrial Cancer
Related Conditions
Top Recruiting Endometrial Cancer Studies
Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation
📍 University of Kentucky — Lexington, Kentucky
View Study & Checklist ➔Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
📍 USA Mitchell Cancer Institute ( Site 4142) — Mobile, Alabama
View Study & Checklist ➔Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
📍 Canberra Hospital — Garran,
View Study & Checklist ➔Activity and Cancer Survivorship Exercise Pilot
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔Abemaciclib and Letrozole to Treat Endometrial Cancer
📍 University of South Alabama Mitchell Cancer Center — Mobile, Alabama
View Study & Checklist ➔Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
📍 Hartford Healthcare (Data Collection) — Hartford, Connecticut
View Study & Checklist ➔Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
📍 UAB Women and Infants Center — Birmingham, Alabama
View Study & Checklist ➔Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
📍 Morristown Memorial Hospital, Women's Cancer Center — Morristown, New Jersey
View Study & Checklist ➔Risk Factors for Endometrial Cancer in Black Women
📍 SUNY Downstate Medical Center — Brooklyn, New York
View Study & Checklist ➔TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
📍 The University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
📍 LSU Health New Orleans — New Orleans, Louisiana
View Study & Checklist ➔A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
📍 Name of Institution: Orlando Health Cancer Institute — Orlando, Florida
View Study & Checklist ➔First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
📍 University of Alabama at Birmingham /ID# 269045 — Birmingham, Alabama
View Study & Checklist ➔Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔Signatera Assessment in Early-Stage Endometrial Cancer
📍 University of Alabama at Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
📍 OU Health Stephenson Cancer Center — Oklahoma City, Oklahoma
View Study & Checklist ➔Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Revealing Engagement Patterns Among Endometrial Cancer Patients
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔Development Of An Endometrial Cancer Educational Tool
📍 UT MD Anderson — Houston, Texas
View Study & Checklist ➔Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
📍 University of California at Los Angeles — Los Angeles, California
View Study & Checklist ➔Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Study of EV for Recurrent Endometrial Carcinoma
📍 Froedtert Memorial Lutheran Hospital — Milwaukee, Wisconsin
View Study & Checklist ➔Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
📍 Princess Margaret Hospital — Toronto, Ontario
View Study & Checklist ➔Fasting InTervention for Endometrial Cancer
📍 University of Miami — Miami, Florida
View Study & Checklist ➔A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
📍 University of South Alabama, Mitchell Cancer Institute ( Site 6033) — Mobile, Alabama
View Study & Checklist ➔Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activites) — Basking Ridge, New Jersey
View Study & Checklist ➔Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
📍 Kaiser Permanente Center — Vallejo, California
View Study & Checklist ➔Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
📍 Cleveland Clinic — Cleveland, Ohio
View Study & Checklist ➔A Study of a Weight Loss Intervention in People With Endometrial Cancer
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
📍 Yale University School of Medicine — New Haven, Connecticut
View Study & Checklist ➔A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔